Mutations in IDH1 or IDH2 genes, which encode isocitrate dehydrogenase enzyme involved in tricarboxylic acid cycle (TCA), are common in lower grade and anaplastic (II–III) glioma [36]. Here, IDH1 is linked to central nervous system cancer.